CAS rejects appeal of Miguel Angel Lopez who will continue to be sanctioned for doping

A blow of justice to Miguel Ángel López. According to Cycle 21, the CAS has dismissed the appeal against his doping sanction. Recall that the UCI had sanctioned him 4 years for menatropin use during the Giro d'Italia 2022.

Thus, the Colombian cyclist will have to serve his full sentence after the CAS refusal (until July 24, 2027), leaving his sporting career practically finished. What CAS has determined is that Lopez was in possession of the aforementioned doping substance (menatropin) and that he would have used it between May 1 and 5, 2022.  

Recall that Lopez was investigated by the Spanish authorities as part of Operation Ilex in a doping scheme led by Dr. Marcos Maynar.

This is how the UCI explained the sanction against Miguel Ángel López at the time:

*Menotropin is a prohibited substance of class S2.2 (peptide hormones and their releasing factors) on the list of prohibited substances and methods maintained by the World Anti-Doping Agency (WADA) and adopted by the UCI.*Menotropin is a prohibited substance of class S2.2 (peptide hormones and their releasing factors) on the list of prohibited substances and methods maintained by the World Anti-Doping Agency (WADA) and adopted by the UCI.